6 results
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
INR Targets and Antiplatelet ... anticoagulants (DOACs ... patients with chronic atrial ... #Management #Cardiology ... #INR #Target #DOAC
Approach to Antithrombotic Therapy in Peripheral Artery Disease
Increased Ischemic Risk:
 • Prior MI
 • Diabetes
 •
Bleeding Risk: • Anticoagulation ... conduit • Poor arterial ... Antithrombotic #management ... peipheralarterialdisease #antiplatelet ... #algorithm #vascular
Anticoagulation for Atrial Fibrillation - CHA2DS2-VASc

I always tell my students, one of the first thing you
for Atrial Fibrillation ... a patient with atrial ... guidelines recommend DOAC ... factor, while ACC ... CHADS2VASC #Score #Management
Antiphospholipid Syndrome (APS)
APS is a rare autoimmune disorder characterized by recurring blood clots resulting from antibodies
confirmed venous, arterial ... patient has an arterial ... target to 3-4 • DOACs ... APS #diagnosis #management ... #anticoagulation
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
Atrial Fibrillation ... risk factors Atrial ... identify left atrial ... test for DM Atrial ... valve • Left atrial
HFpEF and CAD Management Algorithm
1. Consider revascularization based on current guidelines for CAD and HFpEF*
2. Statins:
HFpEF and CAD Management ... Algorithm 1. ... (or equivalent antiplatelet ... with increased arterial ... #Algorithm #cardiology